Estudio PETRO: evaluación de tromboprofilaxis y riesgo embólico en pacientes hospitalizados en una institución de tercer nivel en Bogotá, Colombia
PETRO study: assessment of thromboprophylaxis and embolic risk in hospitalized patients at a third-level institution in Bogota, Colombia
Barra lateral del artículo
PDF
FLIP
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Contenido principal del artículo
Resumen
Palabras clave:
Descargas
Detalles del artículo
Referencias (VER)
Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180-90.
Virchow RC. Cellular pathology as based upon physiological and pathological history. [Tr. from the 2nd. ed. of the original by Frank Chance]. Birmingham; Gryphod Editions, Ltd; 1978.
Dickson BC. Venous thrombosis: on the history of Virchow’s Triad. Univ Toronto Med J. 2004;81:166-71.
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 suppl):338S–400S.
Yamada N, Hanzawa K, Ota S, et al. Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients. Ann Vasc Dis. 2015;8(3):203–9.
Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989;82(4):203-5.
Ashish J. The research priority setting working group of the World alliance for Patient safety. Summary of the evidence on patient safety: implications for research. World Health Organization; 2008.
Abraham Majluf, Espinosa F. Fisiopatología de la trombosis. Medigraphic Anestesia. Gac Med Mexico; 2007.
Lobato-Mendizábal E, Majluf-Cruz A. Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins. Rev Invest Clin. 2000;52:529-45.
Martínez-Murillo C, Quintana-González S, Ambriz-Fernández R, Hernández Paula M. El problema trombótico. Hematología. 2000;1:17-20.
Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387-94.
Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-7.
Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51(1-3):70-8.
Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Semin Thromb Hemost. 1991;17(Suppl 3):304-12.
Rogers SO Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1211-21.
Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr,A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344-50.
Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW et al Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212(1):105-12.
Guyatt GH, Akl EA, Gutterman DD, Schunemann HJ. Antithrombotic therapy and prevention of thrombosis, 9th. ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST. 2012;141(2 suppl)7S-47S. doi: 10.1378/chest.1412S3.
Bick RL. Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism. Drugs. 2000;60(3):575-95.
Gould MK, Debitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute vein thrombosis. A metaanalysis of randomized, controlled trials. Ann Intern Med. 1999;130:800-9.
Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ.2006;332:325-9.
Citado por
